NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) announced the approval of equity awards under its 2021 Inducement Plan, effective August 14, 2024. The awards were granted as a material inducement for three new employees joining the company.
The new hires received options to purchase a total of 23,500 shares of the company’s Class A common stock at an exercise price of $0.6802 per share, the closing price on the date of the grant.
The options have a ten-year term and vest over four years, with 25% vesting each year on the anniversary of the hire date, contingent on continued employment.
The awards align with Nasdaq Listing Rule 5635(c)(4), which mandates public disclosure of such equity awards.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.